Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

Wu-Kong28 Data Support Sunvozertinib as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says

… as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says … Haleigh Behrman …

Tobacco Endgame: A Critical Frontier for Lung Cancer Prevention and Equity

… grocery stores, gas stations, and convenience stores. Research has demonstrated the efficacy of this policy and that … For the lung cancer community, this means supporting research and interventions that address vulnerable populations … use in clinical trials. Advance cross-disciplinary research connecting policy exposure to incidence and outcomes. …

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

… weight gain represents a promising avenue for further research. The successful combination of a GLP-1-RA and a TKI … treatment strategy. A new prospective cohort study by our research group specifically addresses this issue in patients …

Keynote Address Explores the Future of Biomarkers in the ADC Era

… R. Hirsch outlined the current state of knowledge in ADC research, as well as what still needs to be learned. … Keynote …